Fingolimod Attenuates Lung Injury after Diffuse Brain Injury

Author:

Feng Dongyi1,Zhang Xinjie1,Xiang Tangtang1,Su Wanqiang1,Liu Tao1,Li Fanjian1,Qian Yu1,Fan Yibing1,Li Wanjing1,An Shuo1,Tian Yu1,Jiang Rongcai1

Affiliation:

1. Tianjin Medical University General Hospital

Abstract

Abstract One of the severe and common extracranial injuries associated with severe traumatic brain injury (TBI), such as diffuse brain injury (DBI), is acute lung injury (ALI). The inflammatory reaction plays a key role in ALI development. Fingolimod inhibits multiple inflammatory responses. We hypothesized that fingolimod administration could attenuate ALI by modulating the inflammatory reaction secondary to TBI. Fingolimod was administered for 3 consecutive days after DBI. Immunohistochemistry and hematoxylin and eosin staining were performed for histopathological evaluation to assess the degree of inflammatory cell infiltration and ALI after DBI. Pulmonary edema and capillary leakage were quantified by assessing the lung wet-to-dry ratio and Evans blue dye leakage. Western blotting was used to assess the concentrations of inflammatory factors, blood–air barrier tight junction proteins, and apoptosis proteins in lung tissue after DBI. Flow cytometry was used to analyze the peripheral blood Treg content and to evaluate the changes in peripheral immunity after DBI. It was found that DBI induced significant lung injury and caused changes in the peripheral blood Treg content. Fingolimod treatment significantly alleviated lung barrier injury and reduced inflammatory cytokine production, inflammatory cell infiltration, apoptotic protein levels, and the wet/dry weight ratio in lung tissue 3 days after DBI, accompanied by an increase in the peripheral blood Treg content. Thus, it was found that DBI can result in significant pulmonary damage accompanied by significant inflammatory responses. Fingolimod reduced the inflammatory response and alleviated DBI-induced lung injury, providing a potential new approach for the treatment of ALI in DBI.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3